Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918

By sjmartinez • March 12, 2024

Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918. Cancers (Basel). 2024 Mar 1;16(5):1026. doi: 10.3390/cancers16051026. Erratum for: Cancers (Basel). 2020 Jul 16;12(7): PMID: 38473438.

Tags: Endocrinology, General Internal Medicine, King Drew Med Ctr, Publications

Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients

Kalangi ST, Bokka SM, Anand S, Garg R. Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients. Clin Diabetes. 2025 Apr[...]

Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program

Herman WH, Tyndall BD, Duru OK, Moin T, McEwen LN, Shao H, Ackermann RT, Jacobs SR, Neuwahl S, Kuo S, Zhang P, Pavkov ME, Villatoro[...]

Nardilysin in adipocyte regulates insulin sensitivity via HIF1alpha and PPARgamma

Matsuda S, Ohno M, Nishi K, Ikeda S, Iwasaki H, Eifuku T, Hiraoka Y, Kimura T, Ono K, Nishi E. Nardilysin in adipocyte regulates insulin[...]